![](https://static.elsevier.es/multimedia/16652681/0000002900000004/v1_202406280659/en/main.assets/thumbnail/cover.jpeg?image=true&image.size=0x161&idApp=UINPBA00004N)
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
More infoMetabolic Associated Fatty Liver Disease (MAFLD) is a clinic-pathological condition commonly associated with metabolic syndrome (MS) and this association is frequently found in severely obese.
ObjectiveTo compare clinical and histological characteristics of MAFLD in obese with and without MS.
MethodologyCross-sectional study with severely obese patients diagnosed with MAFLD between Sep/2014 and May/2015. MAFLD was diagnosed by liver biopsy during bariatric surgery. MS diagnosis was based on the International Diabetes Federation criteria. Statistical analyses were performed using chi-square and t tests. P<0.05 were considered significant.
ResultsTable 1 shows clinical and histological characteristics of the patients according to the presence of MS.
ConclusionThe results reinforce the relevance of evaluating NAFLD in severely obese by histology. In this simple of obese with MAFLD had hepatic fibrosis, even those without MS.